Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2015 08:01 ET | Source: Traws Pharma, Inc.

Onconova Therapeutics, Inc. to Present New Data on Briciclib and Next-Generation CDK4/6 Inhibitor, ON 123300, at 2015 AACR-NCI-EORTC Meeting

NEWTOWN, Pa., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat...
October 29, 2015 08:00 ET | Source: thromboDx

thromboDx collaborators show Blood Platelets offer all-in-one cancer diagnostics platform; study published in Cancer Cell

AMSTERDAM, Netherlands, Oct. 29, 2015 (GLOBE NEWSWIRE) -- thromboDx, a molecular diagnostic company based in Amsterdam, The Netherlands announced that a 283 subject study shows that its' blood...
October 29, 2015 07:41 ET | Source: Women's Choice Award

Women's Choice Award(R) Recognizes the 2015 America's Best Hospitals for Stroke Care

HOLLYWOOD, Fla., Oct. 29, 2015 (GLOBE NEWSWIRE) -- On Monday, October 26th, the Women's Choice Award®, a trusted referral source for women, released a USA Today announcement honoring America's...
October 29, 2015 07:00 ET | Source: Arno Therapeutics Inc.

Arno Therapeutics Data Demonstrate AR-12 as Novel Antifungal Drug Against Common Finger and Toenail Fungus, Onychomycosis

FLEMINGTON N.J., Oct. 29, 2015 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company primarily focused on the development of therapeutics for cancer and...
October 29, 2015 07:00 ET | Source: Revance Therapeutics, Inc

Revance Reports Positive 6-Month Duration in BELMONT Study

– 6-month duration of effect is statistically significant compared to BOTOX® Cosmetic – – All dose levels of RT002 achieved highly statistically significant,...
October 29, 2015 04:04 ET | Source: Diet Doc Diet and Weight Loss

Diabetic Diet Plans Help Diet Doc Patients Stabilize Blood Sugar Levels, Reduce Type 2 Diabetes Risk and Sustain Healthy Weight Loss Over Time

LOS ANGELES, Oct. 29, 2015 (GLOBE NEWSWIRE) -- Thousands of Americans are diagnosed with diabetes every day. Many more are diagnosed as pre-diabetic and are urged by their physicians to modify their...
October 28, 2015 16:53 ET | Source: Dr. David Amron

Kiss Short-Term Lip Augmentation Goodbye: Dr. David Amron is Among the First in Los Angeles to Plump Aging Lips with FDA-Approved JUVEDERM(r) ULTRA XC

Los Angeles, CA, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Leading dermatologic surgeon Dr. David Amron announced today he now offers the newly FDA-approved JUVEDERM® ULTRA XC to plump and rejuvenate the...
October 28, 2015 16:01 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Presented Phase IIa Results From CAR-T CD20 Immuno-Oncology Clinical Development Program for Advanced B-cell Non-Hodgkin Lymphoma

SHANGHAI, China and CUPERTINO, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of...
October 28, 2015 15:09 ET | Source: Access Scientific

Access Scientific's POWERWAND Midline IV Catheter Sets New Industry Standard for Power Injectabilty

SAN DIEGO, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Access Scientific, LLC today announced validation of the POWERWAND® midline IV catheter for power-injectable capability up to 8ml/sec, 325 psi for up...
October 28, 2015 14:10 ET | Source: Good Samaritan Hospital of San Jose

Good Samaritan Hospital Earned an 'A' Grade for Patient Safety in Leapfrog's Fall 2015 Hospital Safety Score

SAN JOSE, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- An announcement released nationally today by the independent hospital watchdog The Leapfrog Group, shows key shifts among many hospitals on the A,...